safety of glp 1 receptor agonists Top GLP-1 Balance Weight Loss Efficacy, The Safety of GLP1 Receptor
Description
Belzung C
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
The ease of administration and long-term management of diabetes and obesity with oral GLP-1 receptor agonist is driving their widespread adoption
Natarajan K, Xie Y, Baer MR, Ross DD
L.et al (2021)
